it's hugely disappointing. doesn't mean the company is...

it's hugely disappointing. doesn't mean the company is fake though.

the prizma really has nothing else in the market for clinicians/customers to base it off.. so getting them to try something new is a genuinely tough ask. the market just didn't bite on it.. but maybe because of covid/new distribution agreements that will all change... slowly.

the patch on the other hand already has products similar that are doing well in the market. the medical world are a lot more receptive to this product. the fact that the Israeli factory is scaling up aggressively is promising too. I know the company has fallen through with time lines before, but I don't believe they have ever flat out lied to us. often their broken promises have rested on external factors. however, the Israeli production of patches is completely in their control... so i choose to believe there is immediate demand for the products. also I'm not necessarily expecting a PO with them as Yacov always said he was going to give them to hospitals for free. the money comes in from the recurring revenue.